Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma.
- In this study, we assess the effectiveness of autologous cytokine-induced killer cells (CIK) transfusion combined with gemcitabine and cisplatin (GC) chemotherapy for the treatment of nasopharyngeal cancer in patients with distant metastases following radiotherapy.
- As a result, our study suggested that patients with postradiotherapy distant nasopharyngeal carcinoma metastases may benefit better from CIK cell transfusion therapy combined with GC chemotherapy.
- While the 30 patients in the GC group only received GC chemotherapy, the 30 patients in the GC+CIK group also received an adoptive autologous CIK cell transfusion.
To learn more about chemotherapy.
brainly.com/question/12147641
#SPJ4